SLC5A2 and fibrosis: SGLT2 shRNA treatment substantially mitigated diabetes-induced cardiac fibrosis in db/db mice, as shown by Massonʼs staining and immunohistochemistry (Figure 6A, 6B, 6D, and 6E).